The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil

Infection, Genetics and Evolution

Volumn 10, Issue 5, 2010, Pages 607-613

  Ramasawmy, Rajendranath ^a,b,c   Menezes, Eliane ^a   Magalhães, Andrea ^a   Oliveira, Joyce ^a   Castellucci, Léa ^a   Almeida, Roque ^a,d   Rosa, Maria Elisa A ^a   Guimarães, Luiz Henrique ^a   Lessa, Marcus ^a   Noronha, Elza ^e   Wilson, Mary E ^f   Jamieson, Sarra E ^g   Kalil, Jorge ^b,c   Blackwell, Jenefer M ^g,h   Carvalho, Edgar M ^a   de Jesus, Amélia Ribeiro ^a,d  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Instituto de Investigacao em Imunologia   (Brazil)

^d FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^e UNIVERSITY OF BRASILIA   (Brazil)

^f UNIVERSITY OF IOWA   (United States)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

CCL2; Genetic association; MCP 1; Mucosal leishmaniasis

Indexed keywords

ADENINE; GUANINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; BLOOD ANALYSIS; BRAZIL; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; LEISHMANIA BRAZILIENSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN LEISHMANIASIS; SKIN TEST;

ADULT; ANIMALS; BRAZIL; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

LEISHMANIA BRAZILIENSIS;

EID: 77953231854     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2010.04.006     Document Type: Article

References (29)

1. Almeida R.P., Barral-Netto M., De Jesus A.M., De Freitas L.A., Carvalho E.M., Barral A. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice. Am. J. Trop. Med. Hyg. 1996, 54:178-184.
2. Antoniazi S., Price H.P., Kropf P., Freudenberg M.A., Galanos C., Smith D.F., Muller I. Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major. Infect. Immun. 2004, 72:5168-5174.
3. Bacellar O., Lessa H., Schriefer A., Machado P., Ribeiro de Jesus A., Dutra W.O., Gollob K.J., Carvalho E.M. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect. Immun. 2002, 70:6734-6740.
4. Barral A., Pedral-Sampaio D., Grimaldi Junior G., Momen H., McMahon-Pratt D., Ribeiro de Jesus A., Almeida R., Badaro R., Barral-Netto M., Carvalho E.M., et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am. J. Trop. Med. Hyg. 1991, 44:536-546.
5. Bhattacharyya S., Ghosh S., Dasgupta B., Mazumder D., Roy S., Majumdar S. Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J. Infect. Dis. 2002, 185:1704-1708.
6. Cabrera M., Shaw M.-A., Sharples C., Williams H., Castes M., Convit J., Blackwell J.M. Polymorphism in TNF genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 1995, 182:1259-1264.
7. Carvalho E.M., Johnson W.D., Barreto E., Marsden P.D., Costa J.L.M., Reed S., Rocha H. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J. Immunol. 1985, 135:4144-4148.
8. Carvalho L.P., Passos S., Bacellar O., Lessa H., Almeida R.P., Magalhaes A., Dutra W.O., Gollob K.J., Machado P., de Jesus A.R. Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol. 2007, 29:251-258.
9. Castellucci L., Cheng L.H., Araujo C., Guimaraes L.H., Lessa H., Machado P., Almeida M.F., Oliveira A., Ko A., Johnson W.D., Wilson M.E., Carvalho E.M., de Jesus A.R. Familial aggregation of mucosal leishmaniasis in northeast Brazil. Am. J. Trop. Med. Hyg. 2005, 73:69-73.
10. Castellucci L., Menezes E., Oliveira J., Magalhaes A., Guimaraes L.H., Lessa M., Ribeiro S., Reale J., Noronha E.F., Wilson M.E., Duggal P., Beaty T.H., Jeronimo S., Jamieson S.E., Bales A., Blackwell J.M., de Jesus A.R., Carvalho E.M. IL6-174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J. Infect. Dis. 2006, 194:519-527.
11. Cordell H.J., Clayton D.G. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am. J. Hum. Genet. 2002, 70:124-141.
12. Cuba-Cuba C., Llanos-Cuentas E.A., Barreto A.C., Magalhaes A.V., Lago E.L., Reed S., Marsden P.D. Human cutaneous leishmaniasis in Tres Bracos, Bahia, Brasil. An area of Leishmania brazilienses braziliensis transmission. I. Laboratory diagnosis. Rev. Soc. Bras. Med. Trop. 1984, 17:161-167.
13. de Moura T.R., Novais F.O., Oliveira F., Clarencio J., Noronha A., Barral A., Brodskyn C., de Oliveira C.I. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis. Infect. Immun. 2005, 73:5827-5834.
14. Faria D.R., Gollob K.J., Barbosa J.J., Schriefer A., Machado P.R., Lessa H., Carvalho L.P., Romano-Silva M.A., De Jesus A.R., Carvalho E.M., Dutra W.O. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect. Immun. 2005, 73:7853-7859.
15. Flores-Villanueva P.O., Ruiz-Morales J.A., Song C.H., Flores L.M., Jo E.K., Montano M., Barnes P.F., Selman M., Granados J. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J. Exp. Med. 2005, 202:1649-1658.
16. Gonzalez E., Rovin B.H., Sen L., Cooke G., Dhanda R., Mummidi S., Kulkarni H., Bamshad M.J., Telles V., Anderson S.A., Walter E.A., Stephan K.T., Deucher M., Mangano A., Bologna R., Ahuja S.S., Dolan M.J., Ahuja S.K. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13795-13800.
17. Horvath S., Xu X., Laird N.M. The family based association test method: strategies for studying general genotype-phenotype associations. Eur. J. Hum. Genet. 2001, 9:301-306.
18. Laird N.M., Horvath S., Xu X. Implementing a unified approach to family-based tests of association. Genet. Epidemiol. 2000, 19(Suppl. 1):S36-S42.
19. Leonard E.J., Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol. Today 1990, 11:97-101.
20. Marsden P.D., Lessa H.A., Oliveira M.R., Romero G.A., Marotti J.G., Sampaio R.N., Barral A., Carvalho E.M., Cuba C.C., Magalhaes A.V., Macedo V.O. Clinical observations of unresponsive mucosal leishmaniasis. Am. J. Trop. Med. Hyg. 1998, 59:543-545.
21. O'Connell J.R., Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 1998, 63:259-266.
22. Ramasawmy R., Cunha-Neto E., Fae K.C., Martello F.G., Muller N.G., Cavalcanti V.L., Ianni B., Mady C., Kalil J., Goldberg A.C. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin. Infect. Dis. 2006, 43:305-311.
23. Ritter U., Moll H. Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4. Eur. J. Immunol. 2000, 30:3111-3120.
24. Ritter U., Moll H., Laskay T., Brocker E., Velazco O., Becker I., Gillitzer R. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J. Infect. Dis. 1996, 173:699-709.
25. Rosa A.C., Cuba C.C., Vexenat A., Barreto A.C., Marsden P.D. Predominance of Leishmania braziliensis braziliensis in the regions of Tres Bracos and Corte de Pedra, Bahia, Brazil. Trans R. Soc. Trop. Med. Hyg. 1988, 82:409-410.
26. Rovin B.H., Lu L., Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun. 1999, 259:344-348.
27. Salhi A., Rodrigues V., Santoro F., Dessein H., Romano A., Castellano L.R., Sertorio M., Rafati S., Chevillard C., Prata A., Alcais A., Argiro L., Dessein A. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J. Immunol. 2008, 180:6139-6148.
28. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
29. Thye T., Nejentsev S., Intemann C.D., Browne E.N., Chinbuah M.A., Gyapong J., Osei I., Owusu-Dabo E., Zeitels L.R., Herb F., Horstmann R.D., Meyer C.G. MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa. Hum. Mol. Genet. 2009, 18:381-388.